The News Review:

- NCCN Receives $4 Million ncology Research Grant from Wyeth
- Groundbreaking held for new Pennington research center
- Free update for research professionals with an interest in …
- bioRASI Names Gary W. Thompson Vice President of Business Development

NCCN Receives $4 Million ncology Research Grant from Wyeth
PR Newswire (press release) NY 
Investigation of combination therapy with cytotoxics targeted therapies biologic agents and radiation therapy based on hypothesis generating preclinical studies. Identification of biomarkers and molecular imaging that can be used to assess mTR inhibition. The NCCN ncology Research Program (RP) facilitates all phases of clinical research by identifying clinical investigators and initiating trials at NCCN Member Institutions. The RP draws on the expertise of investigators at 21 of the world’s leading cancer centers and establishes collaborations with pharmaceutical and biotech companies in order to advance therapeutic options for patients with cancer. About the National Comprehensive Cancer NetworkThe National Comprehensive Cancer Network (NCCN) a not-for-profit alliance of 21 of the world’s leading cancer centers is dedicated to improving the quality and effectiveness of care provided to patients with cancer. Through the leadership and expertise of clinical professionals at NCCN Member Institutions NCCN develops resources that present valuable information to the numerous stakeholders in the health care delivery system. As the arbiter of high-quality cancer care NCCN promotes the importance of continuous quality improvement and recognizes the significance of creating clinical practice guidelines appropriate for use by patients clinicians and other health care decision-makers.

Groundbreaking held for new Pennington research center
WBXH LA 
Governor Bobby Jindal along with state legislators approved the funding last year. Wednesday they broke ground on the new clinical research building that will use about half of the $50 million allotment. It will be a 90000-square foot facility to expand clinical trials so that researchers can get more grants and answer more scientific questions. The expansion comes as Governor Jindal warns of serious higher education cuts on the horizon. “No I don't think this will be the last investment of its kind” he said. “We're going to have to continue to move the state forward and we'll do that.

Free update for research professionals with an interest in …
S2S Health News Australia 
To facilitate keeping informed AccessCR collates international news that has the potential to impact the way clinical trials are done or the environment for clinical research. For the first time in 2009 this fortnightly update is free to anyone with a professional interest in clinical research as our way of ensuring Australian researchers are connected to what is going on internationally and can use some of those ideas to advance the industry here. The headline format of the AccessCR Update enables clinical research professionals to quickly review two weeks of news while being able to delve further into only those articles they are personally interested in or have the time to do so. Being released fortnightly ensures the email updates cause minimal disruption at a frequency that keeps subscribers informed in a timely manner. Whether you are a clinical research associate project manager clinical investigator study nurse etc or whether affiliated with a pharmaceutical biotechnology medical devices or contract research organisation hospital medical research institute or other research network these updates will provide you with an expanded outlook on the industry with a view towards helping you develop your knowledge and ideas for the way clinical research is done. To find out more about this free update please visit the link below.

bioRASI Names Gary W. Thompson Vice President of Business Development
MSNBC 
In every area he has proved himself a verystrong leader; likeable knowledgeable and well trusted by the industry. In conjunction with the opening of several new offices around the worldGary will lead our efforts providing optimal solutions to our clients’clinical development programs. Prior to joining bioRASI Gary Thompson served as the Vice President ofBusiness Development for Bio Pharma Services as well as the Head ofBusiness Development for Veeda Clinical Research one of the fastestgrowing CRs in India. Previously he has held leading businessdevelopment positions with major CRs including Bioanalytical Systems Inc. (BASi) PPD Pharmaco Inc. and Phoenix International Life Sciences. Story continues below ?advertisement |.
Related from Telefenua: PEI Business Directory warns of telephone call scam